The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization
Open accessAbstract
BACKGROUND: The effect of intensified platelet inhibition for patients with unstable angina or myocardial infarction without ST-segment elevation who do not undergo revascularization has not been delineated. METHODS: In this double-blind, randomized trial, in a primary analysis involving 7243 patients under the age of 75 years receiving aspirin, we evaluated up to 30 months of treatment with prasugrel (10 mg daily) versus clopidogrel (75 mg daily). In a secondary analysis involving 2083 patients 75 years of age or older, we evaluated 5 mg of prasugrel versus 75 mg of clopidogrel. RESULTS: At a median follow-up of 17 months, the primary end point of death from cardiovascular causes, myocardial infarction, or stroke among patients under the age of 75 years occurred in 13.9% of the prasugrel group and 16.0% of the clopidogrel group (hazard ratio in the prasugrel group, 0.91; 95% confidence interval [CI], 0.79 to 1.05; P=0.21). Similar results were observed in the overall population. The prespecified analysis of multiple recurrent ischemic events (all components of the primary end point) suggested a lower risk for prasugrel among patients under the age of 75 years (hazard ratio, 0.85; 95% CI, 0.72 to 1.00; P=0.04). Rates of severe and intracranial bleeding were similar in the two groups in all age groups. There was no significant between-group difference in the frequency of nonhemorrhagic serious adverse events, except for a higher frequency of heart failure in the clopidogrel group. CONCLUSIONS: Among patients with unstable angina or myocardial infarction without ST-segment elevation, prasugrel did not significantly reduce the frequency of the primary end point, as compared with clopidogrel, and similar risks of bleeding were observed. (Funded by Eli Lilly and Daiichi Sankyo; TRILOGY ACS ClinicalTrials.gov number, NCT00699998.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to their initial events, such patients are at substantial risk for recurrent, potentially fatal events.”
From Effects of Icosapent Ethyl on Total Ischemic Events (2019) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790
Self-citationCox’s regression model for counting processes: A large sample study
Andersen, P. K., & Gill, R. D. (1982) · The Annals of Statistics · doi:10.1214/aos/1176345976 · Cited by 4,419
A Prospective Natural-History Study of Coronary Atherosclerosis
Stone, G. W., Maehara, A., Lansky, A. J., Bruyne, B. D., Cristea, E., Mintz, G. S., Mehran, R., McPherson, J., Farhat, N. Z., Marso, S. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1002358 · Cited by 3,301
Authors Task Force Members, Hamm, C. W., Bassand, J., Agewall, S., Bax, J. J., Boersma, E. H., Bueno, H., Caso, P., Dudek, D., Gielen, S., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr236 · Cited by 3,096
Self-citationClopidogrel for Coronary Stenting
Gurbel, P. A., Bliden, K. P., Hiatt, B. L., & O’Connor, C. M. (2003) · Circulation · doi:10.1161/01.cir.0000072771.11429.83 · Cited by 1,544
Self-citationHamm, C. W., Bassand, J., Agewall, S., Bax, J. J., Boersma, E. H., Bueno, H., Caso, P., Dudek, D., Gielen, S., Huber, K., et al. (2012) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2011.11.006 · Cited by 1,062
Self-citationThrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
Tricoci, P., Huang, Z., Held, C., Moliterno, D. J., Armstrong, P. W., de Werf, F. V., White, H. D., Aylward, P. E., Wallentin, L. C., Chen, E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1109719 · Cited by 756
Self-citationWright, R. S., Anderson, J. L., Adams, C. D., Bridges, C. R., Casey, D. E., Ettinger, S. M., Fesmire, F. M., Ganiats, T. G., Jneid, H. M., Lincoff, A. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.011 · Cited by 513
Roe, M. T., Messenger, J. C., Weintraub, W. S., Cannon, C. P., Fonarow, G. C., Dai, D., Chen, A. Y., Klein, L. W., Masoudi, F. A., McKay, C. R., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.008 · Cited by 447
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 873
Verdoia, M., Schaffer, A., Barbieri, L., Cassetti, E., Piccolo, R., Galasso, G., Marino, P. N., Sinigaglia, F., & Luca, G. D. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000052 · Cited by 73
Goggs, R. A. N., Blais, M., Brainard, B. M., Chan, D. L., deLaforcade, A. M., Rozanski, E. A., & Sharp, C. R. (2019) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/vec.12801 · Cited by 78
Garratt, K. N., Weaver, W. D., Jenkins, R. G., Pow, T. K., Mauri, L., Kereiakes, D. J., Winters, K. J., Christen, T., Allocco, D. J., & Lee, D. P. (2014) · Circulation · doi:10.1161/circulationaha.114.013570 · Cited by 72
Self-citationChanges in thrombus composition and profilin-1 release in acute myocardial infarction
Ramaiola, I., Padró, T., Peña, E., Juan‐Babot, O., Cubedo, J., Martín‐Yuste, V., Sabaté, M., & Badimón, L. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu356 · Cited by 72
Валерьевич, А. О., HARUTYUNYAN, G., Duplyakov, D. V., Константинова, Е. В., Konstantinova, N. N., Shakhnovich, R. M., Yavelov, I. S., Yakovlev, A. N., Sa, A., Alekyan, B. G., et al. (2025) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6306 · Cited by 86
Capodanno, D., & Angiolillo, D. J. (2014) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.113.001150 · Cited by 73
Potent P2Y 12 Inhibitors in Men Versus Women
Lau, E. S., D, E. B. M., Murphy, S. A., Wiviott, S. D., Bonaca, M. P., Husted, S., James, S. K., Wallentin, L. C., Clemmensen, P. M., Roe, M. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.01.028 · Cited by 72
Self-citationRandomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients With Diabetes
Alexopoulos, D. K., Xanthopoulou, I., Mavronasiou, E., Stavrou, K., Siapika, A., Tsoni, E., & Davlouros, P. A. (2013) · Diabetes Care · doi:10.2337/dc12-2510 · Cited by 70
Intracranial Hemorrhage During Dual Antiplatelet Therapy
Ha, A. C. T., Bhatt, D. L., Rutka, J. T., Johnston, S. C., Mazer, C. D., & Verma, S. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.07.048 · Cited by 73
Self-citationThe Perioperative Management of Treatment With Anticoagulants and Platelet Aggregation Inhibitors
Schlitt, A., Jámbor, C., Spannagl, M., Gogarten, W., Schilling, T., & Zwißler, B. (2013) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2013.0525 · Cited by 68
Management of Patients With NSTE-ACS
Rodríguez, F., & Mahaffey, K. W. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.599 · Cited by 69
Bavishi, C., Panwar, S. R., Messerli, F. H., & Bangalore, S. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.05.058 · Cited by 65
Gagne, J. J., Bykov, K., Choudhry, N. K., Toomey, T., Connolly, J. G., & Avorn, J. (2013) · BMJ · doi:10.1136/bmj.f5307 · Cited by 66
De-Escalation of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndromes
Shoji, S., Kuno, T., Fujisaki, T., Takagi, H., Briasoulis, Α., Deharo, P., Cuisset, T., Latib, A., & Kohsaka, S. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.06.012 · Cited by 66
Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease
Valgimigli, M., Aboyans, V., Angiolillo, D. J., Atar, D., Capodanno, D., Halvorsen, S., James, S. K., Jüni, P., Kunadian, V., Landi, A., et al. (2023) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvad032 · Cited by 66
Self-citationYun, J. E., Kim, Y. J., Park, J. J., Kim, S., Park, K., Cho, M. S., Nam, G., & Park, D. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012078 · Cited by 64
Clinical evidence for oral antiplatelet therapy in acute coronary syndromes
Wiviott, S. D., & Steg, P. G. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60213-6 · Cited by 64
Généreux, P., Giustino, G., Redfors, B., Palmerini, T., Witzenbichler, B., Weisz, G., Stuckey, T., Maehara, A., Mehran, R., Kirtane, A. J., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.03.103 · Cited by 62
Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial
Bakal, J. A., Roe, M. T., Ohman, E. M., Goodman, S. G., Fox, K. A. A., Zheng, Y., Westerhout, C. M., Hochman, J. S., Lokhnygina, Y., Brown, E. B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu262 · Cited by 59
Self-citationBrieger, D. B., Cullen, L., Briffa, T. G., Zaman, S. J., Scott, I. A., Papendick, C., Bardsley, K., Baumann, A. A. W., Bennett, A., Clark, R. A., et al. (2025) · Heart Lung and Circulation · doi:10.1016/j.hlc.2025.02.102 · Cited by 68
Melloni, C., Cornel, J. H., Hafley, G. E., Neely, M. L., Clemmensen, P. M., Zamoryakhin, D., Prabhakaran, D., White, H. D., Fox, K. A. A., Ohman, E. M., et al. (2015) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872615598631 · Cited by 59
Self-citationTreatment and prevention of gastrointestinal bleeding in patients receiving antiplatelet therapy
Yasuda, H. (2015) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v4.i1.40 · Cited by 60
Clemmensen, P. M., Grieco, N. B., İnce, H., Danchin, N., Gödicke, J., Ramos, Y., Schmitt, J., Goldstein, P., & on behalf of the MULTIPRAC study investigators (2014) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872614547449 · Cited by 58
Self-citationState of the Art in Platelet Function Testing
Kehrel, B. E., & Brodde, M. F. (2013) · Transfusion Medicine and Hemotherapy · doi:10.1159/000350469 · Cited by 57
Li, Y., Wang, Y.-C., Wang, Y., Liu, J., Lee, C., Chen, C., Hsieh, C., Kuo, F. Y., Huang, W., Sung, S., et al. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.06.002 · Cited by 57
Montalescot, G., Rangé, G., Silvain, J., Bonnet, J., Boueri, Z., Barthélémy, O., Cayla, G., Belle, L., BELLE, E. V., Cuisset, T., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.007524 · Cited by 55
Ticagrelor or Prasugrel in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes
Valina, C. M., Neumann, F., Menichelli, M., Mayer, K., Wöhrle, J., Bernlochner, I., Aytekin, A., Richardt, G., Witzenbichler, B., Sibbing, D., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.09.584 · Cited by 58
Self-citationEmerging roles of platelets in cancer biology and their potential as therapeutic targets
Wang, L., Wang, X., Guo, E., Mao, X., & Miao, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.939089 · Cited by 55
Platelet Abnormalities in CKD and Their Implications for Antiplatelet Therapy
Baaten, C. C. F. M. J., Schröer, J. R., Flöge, J., Marx, N., Jankowski, J., Berger, M., & Noels, H. (2022) · RWTH Publications (RWTH Aachen) · Cited by 54
Watson, R. A., Johnson, D. M., Dharia, R. N., Merli, G. J., & Doherty, J. U. (2020) · Hospital Practice · doi:10.1080/21548331.2020.1772639 · Cited by 55
Diabetes and antiplatelet therapy: from bench to bedside
Rios, J. R. R., Franchi, F., Rollini, F., & Angiolillo, D. J. (2018) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2018.05.09 · Cited by 52
Modern Management of ST-Segment Elevation Myocardial Infarction
Frampton, J., DeVries, J. T., Welch, T. D., & Gersh, B. J. (2018) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2018.08.005 · Cited by 53
Huo, Y., Jeong, Y., Gong, Y., Wang, D. W., He, B., Chen, J., Fu, G., Chen, Y., Li, J., Li, Y., et al. (2018) · 中国科学通报：英文版 · doi:10.1016/j.scib.2018.12.020 · Cited by 52
Self-citationNicolau, J. C., Timerman, A., Marin‐Neto, J. A., Piegas, L. S., Dornas, C. J. C. B., Franci, A., Avezum, A., Carvalho, A., Filho, B. M., Polanczyk, C. A., et al. (2014) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.2014s001 · Cited by 51
Self-citationOverview of pleiotropic effects of platelet P2Y12 receptor inhibitors
Koziński, M., Ostrowska, M., Fabiszak, T., Navarese, E. P., Paciorek, P., Grześk, G., Kubica, J., & Adamski, P. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-11-0915 · Cited by 51
New Approaches to Inhibiting Platelets and Coagulation
Depta, J. P., & Bhatt, D. L. (2015) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124438 · Cited by 51
Self-citationCauses of late mortality with dual antiplatelet therapy after coronary stents
Mauri, L., Elmariah, S., Yeh, R. W., Cutlip, D. E., Steg, P. G., Windecker, S., Wiviott, S. D., Cohen, D. J., Massaro, J. M., D’Agostino, R. B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv614 · Cited by 51
Weitz, J. I. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-03-0265 · Cited by 50
Galli, M., Franchi, F., Rollini, F., Cavallari, L. H., Capodanno, D., Crea, F., & Angiolillo, D. J. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1927709 · Cited by 50
Damman, P., Varenhorst, C., Koul, S. M., Eriksson, P., Erlinge, D., Lagerqvist, B., & James, S. K. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.09.019 · Cited by 49
Antithrombotic therapy for acute coronary syndrome: Past, present and future
Sibbing, D., Angiolillo, D. J., & Huber, K. (2017) · Thrombosis and Haemostasis · doi:10.1160/th16-12-0963 · Cited by 50
Self-citationFerreiro, J. L., Bhatt, D. L., Ueno, M., Bauer, D., & Angiolillo, D. J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.043 · Cited by 49
Self-citationKomócsi, A., Vorobcsuk, A., Serebruany, V. L., & Aradi, D. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-06-0377 · Cited by 48
Advances in mechanisms, imaging and management of the unstable plaque
Niccoli, G., Liuzzo, G., Montone, R. A., & Crea, F. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.01.036 · Cited by 49
Valgimigli, M. (2014) · Circulation · doi:10.1161/circulationaha.114.011319 · Cited by 47
Solid cancers after antiplatelet therapy: Confirmations, controversies, and challenges
Cherepanov, V., Cabrera-Fuentes, H. A., Kim, M. H., & Serebruany, V. L. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-01-0077 · Cited by 47
Collet, J., Silvain, J., Bellemain-Appaix, A., & Montalescot, G. (2014) · Circulation · doi:10.1161/circulationaha.114.011320 · Cited by 44
Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in Switzerland
Klingenberg, R., Heg, D., Räber, L., Carballo, D., Nanchen, D., Gencer, B., Auer, R., Jaguszewski, M. J., Stähli, B. E., Jakob, P., et al. (2015) · Heart · doi:10.1136/heartjnl-2014-306925 · Cited by 45
Ke, J., Chen, Y., Wang, X., Wu, Z., Zhang, Q., Lian, Y., & Chen, F. (2022) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2021.12.070 · Cited by 48
Kuno, T., Watanabe, A., Shoji, S., Fujisaki, T., Ueyama, H. A., Takagi, H., Deharo, P., Cuisset, T., Bangalore, S., Mehran, R., et al. (2023) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.123.013242 · Cited by 44
Self-citationLevine, G. N., Jeong, Y., Goto, S., Anderson, J. L., Huo, Y., Mega, J. L., Taubert, K. A., & Smith, S. C. (2014) · Global Heart · doi:10.1016/j.gheart.2014.08.001 · Cited by 43
Angiolillo, D. J., & Ferreiro, J. L. (2013) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-013-0022-7 · Cited by 42
Diodati, J. G., Saucedo, J. F., French, J. K., Fung, A., Cardillo, T. E., Henneges, C., Effron, M. B., Fisher, H. N., & Angiolillo, D. J. (2013) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.112.000063 · Cited by 44
Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes
Alfredsson, J., Neely, B., Neely, M. L., Bhatt, D. L., Goodman, S. G., Tricoci, P., Mahaffey, K. W., Cornel, J. H., White, H. D., Fox, K. A. A., et al. (2017) · Heart · doi:10.1136/heartjnl-2016-310090 · Cited by 44
Self-citationCohen, M. V., & Downey, J. M. (2013) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248413508465 · Cited by 42
Martínez‐Sánchez, C., Borrayo, G., Carrillo, J., Juarez, U., Quintanilla, J., & Carlos Jerjes-Sánchez, D. (2016) · Archivos de cardiología de México · doi:10.1016/j.acmx.2016.04.007 · Cited by 42
Crimi, G., Morici, N., Ferrario, M., Ferri, L., Piatti, L., Grosseto, D., Cacucci, M., Mirizzi, A. M., Toso, A., Piscione, F., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010956 · Cited by 42
Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease
Coppens, M., Weitz, J. I., & Eikelboom, J. W. (2019) · Circulation Research · doi:10.1161/circresaha.118.313141 · Cited by 42
Bainey, K. R., Marquis‐Gravel, G., Belley‐Côté, E. P., Turgeon, R. D., Ackman, M. L., Babadagli, H. E., Bewick, D. J., Boivin‐Proulx, L., Cantor, W. J., Fremes, S. E., et al. (2023) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2023.10.013 · Cited by 46
Binsaleh, N. K., Wigley, C. A., Whitehead, K. A., van Rensburg, M., Reynisson, J., Pilkington, L. I., Barker, D. L. A., Jones, S., & Dempsey‐Hibbert, N. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.11.014 · Cited by 41
D’Ascenzo, F., Biolè, C., Raposeiras‐Roubín, S., Gaido, F., Abu‐Assi, E., Kinnaird, T. D., Ariza‐Solé, A., Liebetrau, C., Manzano‐Fernández, S., Boccuzzi, G. G., et al. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.10.001 · Cited by 41
Huber, K., Bates, E., Valgimigli, M., Wallentin, L. C., Kristensen, S. D., Anderson, J. L., Sendón, J. L. L., Marco Tubaro, U., Granger, C. B., Bode, C., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.06.014 · Cited by 40
Self-citationManagement of Acute Coronary Syndromes in Geriatric Patients
Padilla, I. M., Martín‐Asenjo, R., & Bueno, H. (2016) · Heart Lung and Circulation · doi:10.1016/j.hlc.2016.07.008 · Cited by 40
Antiplatelet Therapy in Acute Coronary Syndrome
Layne, K. A., & Ferro, A. (2017) · European Cardiology Review · doi:10.15420/ecr.2016:34:2 · Cited by 40
Role of diabetes in stroke: Recent advances in pathophysiology and clinical management
Bradley, S., Spring, K. J., Beran, R. G., Chatzis, D., Killingsworth, M. C., & Bhaskar, S. M. M. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3495 · Cited by 42
Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel
Doll, J. A., Neely, M. L., Roe, M. T., Armstrong, P. W., White, H. D., Prabhakaran, D., Winters, K. J., Duvvuru, S., Sundseth, S. S., Jakubowski, J. A., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.12.036 · Cited by 39
Self-citationHess, C. N., Clare, R. M., Neely, M. L., Tricoci, P., Mahaffey, K. W., James, S. K., Alexander, J. H., Held, C., Lópes, R. D., Fox, K. A. A., et al. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.01.016 · Cited by 39
Self-citationBuccheri, S., Capodanno, D., James, S. K., & Angiolillo, D. J. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1680637 · Cited by 40
Hartmann‐Petersen, R., & Gordon, C. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4132-x · Cited by 41
Furtado, R. H. M., Nicolau, J. C., Magnani, G., Im, K., Bhatt, D. L., Storey, R. F., Steg, P. G., Špinar, J., Budaj, A., Kontny, F. P., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz821 · Cited by 38
Self-citationKuno, T., Fujisaki, T., Shoji, S., Sahashi, Y., Tsugawa, Y., Iwagami, M., Takagi, H., Briasoulis, Α., Deharo, P., Cuisset, T., et al. (2022) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.122.011990 · Cited by 37
Self-citationAntiplatelet therapy in acute coronary syndromes
Grove, E. L., Würtz, M., Thomas, M. R., & Kristensen, S. D. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1079619 · Cited by 38
Gulizia, M. M., Colivicchi, F., Abrignani, M. G., Ambrosetti, M., Aspromonte, N., Barile, G., Caporale, R., Casolo, G., Chiuini, E., Lenarda, A. D., et al. (2018) · European Heart Journal Supplements · doi:10.1093/eurheartj/suy019 · Cited by 38
D’Ascenzo, F., Bertaina, M., Fioravanti, F., Bongiovanni, F., Raposeiras‐Roubín, S., Abu‐Assi, E., Kinnaird, T. D., Ariza‐Solé, A., Manzano‐Fernández, S., Templin, C., et al. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319836327 · Cited by 37
Schreuder, M. M., Badal, R., Boersma, E. H., Kavousi, M., Roos‐Hesselink, J. W., Versmissen, J., Visser, L. E., & van Lennep, J. E. R. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014457 · Cited by 37
Antiplatelet therapy for secondary prevention of coronary artery disease
Pilgrim, T., & Windecker, S. (2014) · Heart · doi:10.1136/heartjnl-2013-305399 · Cited by 36
New directions for pharmacotherapy in the treatment of acute coronary syndrome
Adamski, P., Adamska, U., Ostrowska, M., Koziński, M., & Kubica, J. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1241234 · Cited by 36
Nicolau, J. C., Bhatt, D. L., Roe, M. T., Lokhnygina, Y. V., Neely, B., Corbalan, R. L., Leiva-Pons, J. L., Martínez, F. A., Goodman, S. G., Winters, K. J., et al. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.05.017 · Cited by 36
Self-citationGoto, S., Hasebe, T., & Takagi, S. (2015) · Circulation Journal · doi:10.1253/circj.cj-14-1434 · Cited by 36
Westman, P. C., Lipinski, M. J., Torguson, R., & Waksman, R. (2016) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2016.10.005 · Cited by 36
Bonello, L., Laine, M., Cluzel, M., Frère, C., Mancini, J., Hasan, A., Thuny, F., Gaubert, M., Guieu, R., Dignat‐George, F., et al. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.04.050 · Cited by 35
Capodanno, D., Alberts, M. J., & Angiolillo, D. J. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.111 · Cited by 34
Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective
Tersalvi, G., Biasco, L., Cioffi, G. M., & Pedrazzini, G. B. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072064 · Cited by 35
Weissler, E. H., Jones, W. S., Désormais, I., Debus, S., Mazzolai, L., Espinola–Klein, C., Nikol, S., Nehler, M. R., Sillesen, H. H., Aboyans, V., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.11.001 · Cited by 35
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
(2020) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2020.05.011 · Cited by 36
Platelet pathophysiology, pharmacology, and function in coronary artery disease
Ibrahim, H., & Kleiman, N. S. (2017) · Coronary Artery Disease · doi:10.1097/mca.0000000000000519 · Cited by 37
Role of phenotypic and genetic testing in managing clopidogrel therapy
Chan, N., Eikelboom, J. W., Ginsberg, J. S., Lauw, M. N., Vanassche, T., Weitz, J. I., & Hirsh, J. (2014) · Blood · doi:10.1182/blood-2014-01-512723 · Cited by 35
Contemporary Use of Prasugrel in Clinical Practice
Sandhu, A., Seth, M., Dixon, S. R., Share, D. A., Wohns, D., Lalonde, T. A., Moscucci, M. M., Riba, A. L., Grossman, P. M., & Gurm, H. S. (2013) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.111.000060 · Cited by 34
Hicks, B. M., Murray, L., Hughes, C. M., & Cardwell, C. R. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3807 · Cited by 35
Sudden Cardiac Death After Non–ST-Segment Elevation Acute Coronary Syndrome
Hess, P. L., WOJDYLA, D. M., Al‐Khatib, S. M., Lokhnygina, Y. V., Wallentin, L. C., Armstrong, P. W., Roe, M. T., Ohman, E. M., Harrington, R. A., Alexander, J. H., et al. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2015.0359 · Cited by 34
Self-citationWang, A., Kwee, L. C., Grass, E. A., Neely, M. L., Gregory, S. G., Fox, K. A. A., Armstrong, P. W., White, H. D., Ohman, E. M., Roe, M. T., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.03.041 · Cited by 36
Self-citationUpdate on antithrombotic therapy after percutaneous coronary revascularisation
Cuisset, T., Verheugt, F. W. A., & Mauri, L. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31936-0 · Cited by 35
Jang, A. Y., Park, S., Lee, J. P., Choi, S. H., Kong, M. G., Won, Y. S., Kim, M.-S., Lee, K. H., Han, S. H., Kwon, S. W., et al. (2025) · EuroIntervention · doi:10.4244/eij-d-25-00331 · Cited by 40
Lhermusier, T., Lipinski, M. J., Tantry, U. S., Escarcega, R. O., Baker, N. C., Bliden, K. P., Magalhães, M. A., Ota, H., Tian, W., PENDYALA, L. K., et al. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.12.029 · Cited by 33
Self-citationTicagrelor: A Review of Its Use in Adults with Acute Coronary Syndromes
Dhillon, S. (2015) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-015-0108-5 · Cited by 34
Solomon, M. D., Go, A. S., Shilane, D. A., Boothroyd, D. B., Leong, T. K., Kazi, D. S., Chang, T. I., & Hlatky, M. A. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.586 · Cited by 32
Zaccardi, F., Pitocco, D., Willeit, P., & Laukkanen, J. A. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.015 · Cited by 33
Tornyos, A., Kehl, D., D’Ascenzo, F., & Komócsi, A. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.12.001 · Cited by 33
Fanaroff, A. C., Hasselblad, V., Roe, M. T., Bhatt, D. L., James, S. K., Steg, P. G., Gibson, C. M., & Ohman, E. M. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.03.046 · Cited by 32
Self-citationAntiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease
Lettino, M., Leonardi, S., Maria, E. D., & Halvorsen, S. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317707854 · Cited by 32
Metadata
- Authors
- Roe, M. T., Armstrong, P. W., Fox, K. A. A., White, H. D., Prabhakaran, D., Goodman, S. G., Cornel, J. H., Bhatt, D. L., Clemmensen, P., Martinez, F., Ardissino, D., Nicolau, J. C., Boden, W. E., Gurbel, P. A., Ruzyllo, W., Dalby, A. J., McGuire, D. K., Leiva-Pons, J. L., Parkhomenko, A., Gottlieb, S., Topacio, G. O., Hamm, C., Pavlides, G., Goudev, A. R., Oto, A., Tseng, C.-D., Merkely, B., Gasparovic, V., Corbalan, R., Cinteză, M., McLendon, R. C., Winters, K. J., Brown, E. B., Lokhnygina, Y., Aylward, P. E., Huber, K., Hochman, J. S., & Ohman, E. M.
- Affiliations
- Duke Medical Center (US)
- University of Alberta (CA)
- Duke University (US)
- St. Michael's Hospital (CA)
- Brigham and Women's Hospital (US)
- University of Copenhagen (DK)
- National Taiwan University (TW)
- Eli Lilly (United States) (US)
- Flinders University (AU)
- ORCID
- Roe, Matthew T.
- Armstrong, Paul W.
- Fox, Keith A.A.
- White, Harvey D.
- Prabhakaran, Dorairaj
- Goodman, Shaun G.
- Cornel, Jan H.
- Bhatt, Deepak L.
- Clemmensen, Peter
- Ardissino, Diego
- Boden, William E.
- Gurbel, Paul A.
- McGuire, Darren K.
- Leiva-Pons, Jose L.
- Parkhomenko, Alexander
- Gottlieb, Shmuel
- Hamm, Christian
- Goudev, Assen R.
- Oto, Ali
- Aylward, Philip E.
- Huber, Kurt
- Hochman, Judith S.
- Ohman, E. Magnus
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-10-04
- Volume
- 367
- Issue
- 14
- Pages
- 1297-1309
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2109577952
- Cited by
- 874
- References
- 18
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 14 · 2023: 31 · 2022: 43 · 2021: 49 · 2020: 58 · 2019: 53 · 2018: 70 · 2017: 92 · 2016: 71 · 2015: 91 · 2014: 114 · 2013: 124 · 2012: 20
- FWCI
- 71.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Scientific Electronic Library Online (São Paulo Research Foundation, Latin American and Caribbean Center on Health Sciences Information, Conselho Nacional de Desenvolvimento Científico e Tecnológico) (publishedVersion)
- Trakya University's Institutional Open Access System (Trakya University) (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Hacettepe University Institutional Repository (hacettepe.edu.tr) (submittedVersion, other-oa)
- ORBi (University of Liège) (submittedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Abbott Laboratories
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Amylin Pharmaceuticals
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Gilead Sciences
- Helsinn
- Boston Scientific Corporation
- Boston VA Research Institute
- Regeneron Pharmaceuticals
- Amarin Corporation
- Medicines Company
- Regado Biosciences
- Eisai
- Astellas Pharma
- Servier
- Genentech
- Janssen Pharmaceuticals
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Keywords
- prasugrel, clopidogrel, acute coronary syndrome, non-ST-elevation myocardial infarction, unstable angina, platelet aggregation inhibition, antiplatelet therapy, bleeding risk, heart failure, cardiovascular mortality, stroke, elderly patients
- MeSH terms
- Prasugrel Hydrochloride, Clopidogrel, Aged, Angina, Unstable, Aspirin, Cardiovascular Diseases, Double-Blind Method, Drug Therapy, Combination, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Piperazines, Platelet Aggregation Inhibitors, Thiophenes, Ticlopidine, Stroke, Kaplan-Meier Estimate, Acute Coronary Syndrome, Purinergic P2 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
